Mark B.

Research & Design | Business Development | Strategy | Life Sciences | Finance

United Kingdom of Great Britain and Northern Ireland
EN

I have over 28 years of experience in the life sciences and financial sectors, with operational and Board experience covering the value chain in life sciences. My areas of expertise include executive ...see more

  • Biotechnology & Life Sciences

450

/hr
  • Pre-vetted expert
  • Confirmed hourly rate
  • Available on short notice

Experience

Senior Board Advisor

UTILITY therapeutics
2 years
Current position
Mar 2020 - Present
UTILITY therapeutics is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resis...see more

Chief Executive Officer

Sutura Therapeutics
3 years
Current position
Aug 2019 - Present
April 2020 - Present: Chief Executive Officer Sept 2019 - March 2020: Non-Executive Director Sutura Therapeutics is an innovative company developing RNA-targeted therapeutics focussed o...see more

Chief Executive Officer

UTILITY therapeutics
2 years
Nov 2017 - Feb 2020
UTILITY therapeutics is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resis...see more

Group Chief Financial Officer

Celixir
11 months
Dec 2016 - Nov 2017
Celixir was co-founded by Professor Sir Martin Evans, the 2007 Nobel Laureate and Ajan Reginald, ex-Global Head of Emerging Technologies, Roche. Celixir develops cellular medicines to...see more

Executive Board Member

Cell Therapy Limited
3 years
Apr 2015 - Nov 2017
Cell Therapy Limited (CTL) is a private UK regenerative medicine company that has discovered and developed a pipeline of novel cellular medicines in areas of high unmet clinical need.

Director of Corporate Development

Celixir
2 years
Apr 2015 - Dec 2016
Celixir was co-founded by Professor Sir Martin Evans, the 2007 Nobel Laureate and Ajan Reginald, ex-Global Head of Emerging Technologies, Roche. Celixir develops cellular medicines to...see more

Director, Healthcare and Life Sciences Strategy

KPMG
1 year
Nov 2013 - Mar 2015
KPMG provides insightful and experienced perspectives that help world leaders navigate the complexity of today’s changing marketplace to create and protect the sustainable value oftheir...see more

Vice President, Co-lead European Life Sciences

Charles River Associates
2 years
May 2012 - Nov 2013
Charles River Associates® is a global strategic and economics consulting firm, guiding corporations through critical business strategy and performance-related issues.

Vice President, Head of Equity Research, Healthcare

Goldman Sachs
2 years
Feb 2010 - May 2012
Led sell-side research team covering large- and mid-cap European Pharmaceutical companies, and European Medtech companies.

Engagement Manager

McKinsey & Company
3 years
Jan 2007 - Feb 2010
Projects included: - Launch strategy for product in new therapy area for top 5 pharmaco - Corporate strategy development for top 10 global pharmaceutical company in emerging markets - V...see more

Global Strategy Manager

GlaxoSmithKline
5 years
Dec 2001 - Dec 2006
Commercial Strategy Manager, Autoimmune Diseases - GlaxoSmithKline R&D, 2005 – Feb 2007 - Commercial lead in due diligence, negotiations and deal structure for numerous in-license targe...see more

International Business Development Manager

Abbott Laboratories
1 year
Dec 2000 - Dec 2001
International Marketing & Business Development Manager - Abbott Laboratories, Chicago, 2001 – 2002 - Co-ordinated launch of urology product across 30 major global markets - Developed po...see more

Industries, roles and expertise

Industry experience

  • Biotechnology & Life Sciences

Expertise

  • Competitive Analysis
  • Business Strategy
  • Market Analysis
  • Business Development
  • Corporate Development
  • Commercialization
  • Market Entry
  • Product Lifecycle Management
  • Global Marketing